ATE144250T1 - 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung - Google Patents

26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung

Info

Publication number
ATE144250T1
ATE144250T1 AT92311681T AT92311681T ATE144250T1 AT E144250 T1 ATE144250 T1 AT E144250T1 AT 92311681 T AT92311681 T AT 92311681T AT 92311681 T AT92311681 T AT 92311681T AT E144250 T1 ATE144250 T1 AT E144250T1
Authority
AT
Austria
Prior art keywords
dihydroxyvitamin
alpha
activity
dimethylene
production
Prior art date
Application number
AT92311681T
Other languages
English (en)
Inventor
Hector Floyd Deluca
Naoshi Nakagawa
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE144250T1 publication Critical patent/ATE144250T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92311681T 1991-12-26 1992-12-22 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung ATE144250T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81385291A 1991-12-26 1991-12-26

Publications (1)

Publication Number Publication Date
ATE144250T1 true ATE144250T1 (de) 1996-11-15

Family

ID=25213574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92311681T ATE144250T1 (de) 1991-12-26 1992-12-22 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (3) US5397775A (de)
EP (1) EP0549318B1 (de)
JP (1) JP3195452B2 (de)
KR (1) KR100202434B1 (de)
AT (1) ATE144250T1 (de)
AU (1) AU656829B2 (de)
DE (1) DE69214617T2 (de)
IL (1) IL104201A0 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104201A0 (en) * 1991-12-26 1993-05-13 Wisconsin Alumni Res Found 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5373004A (en) * 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
KR100593238B1 (ko) * 1997-06-25 2006-06-26 데이진 가부시키가이샤 비타민 ｄ3 유도체 및 이로부터 제조된 염증성 호흡기 질환 치료제
IT1311922B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CN102531948A (zh) * 2002-03-08 2012-07-04 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
SG173119A1 (en) * 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN105663146B (zh) 2009-08-14 2020-09-11 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
JP2711161B2 (ja) * 1988-04-21 1998-02-10 レオ・ファーマシューティカル・プロダクツ・リミテッド・エイ／エス（レーベンス・ケミスケ・ファブリック・プロデュクチオンスアクチーセルスカブ） 新規ビタミンｄ類似体
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
IL104201A0 (en) * 1991-12-26 1993-05-13 Wisconsin Alumni Res Found 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0549318B1 (de) 1996-10-16
AU656829B2 (en) 1995-02-16
JPH05271183A (ja) 1993-10-19
IL104201A0 (en) 1993-05-13
DE69214617D1 (de) 1996-11-21
JP3195452B2 (ja) 2001-08-06
KR100202434B1 (ko) 1999-06-15
AU3036292A (en) 1993-07-01
US5397775A (en) 1995-03-14
US5478955A (en) 1995-12-26
DE69214617T2 (de) 1997-05-28
EP0549318A3 (en) 1993-10-06
US5494906A (en) 1996-02-27
EP0549318A2 (de) 1993-06-30

Similar Documents

Publication Publication Date Title
ATE123767T1 (de) 24-cyclopropan-vitamin-d-derivate.
ATE165819T1 (de) 26,28-methylen-1alpha,25-dihydroxy-vitamin-d2- verbindungen
ATE144250T1 (de) 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung
NO972258D0 (no) 18, 19-dinor-vitamin D-forbindelser
HU902288D0 (en) Process for producing new epimers of 1-alpha-hydroxy-d vitamin and their derivatives as well as pharmaceutical preparatives containing these compounds
EP0550702A4 (en) Methods for preparation and use of 1-g(a),24-dihydroxy vitamin d 2?
ES2009278A6 (es) Procedimiento para la preparacion de sulfato calcico alfa-hemidrato a partir de sulfato calcico dihidrato finamente dividido.
ATE186728T1 (de) Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung
NZ190939A (en) Fluoro-derivatives of vitamin d
IE891406L (en) Compounds effective in inducing cell differentiation and¹process for preparing same
AU4444793A (en) Preparation of 19-nor-vitamin D compounds
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
ATE99946T1 (de) Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung.
DE59501808D1 (de) Verfahren zur kontinuierlichen Herstellung von alpha-Calciumsulfat-Halbhydrat aus Calciumsulfat-Dihydrat
ES2061293T3 (es) Procedimiento para el acondicionamiento y/o purificacion de isocianatos organicos.
DE3582345D1 (de) Verfahren zur herstellung eines optisch aktiven lactons und neue zwischenprodukte in diesem verfahren.
ES2130148T3 (es) Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion.
MX9703720A (es) Compuestos de 18-nor-vitamina d.
JPS5524105A (en) Method and agent for control of calcium metabolism of warm-blooded animal
DE69108319T2 (de) Verfahren zur herstellung von vitamin-d2-verbindungen und ihrer 1-alpha hydrogenierten derivate.
ES2066413T3 (es) Procedimiento para la purificacion de n,n-dietilmandelamida.
ATE280173T1 (de) Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties